These five high-yield dividend stocks with solid upside potential and Buy ratings make sense for growth and income investors ...

Okay, no, look, I’m a Eli Lilly guy, okay? I’m going to stick with it. If I’m going to do Viking, I’m going to do Viking ...

Given the stock's less-than favorable performance during the last few years as it emerged from its pandemic growth days and ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to ...

Quick Read Enbridge plans to add $8B in new projects next year to boost cash flow and dividend capacity. Pfizer generated $14B in free cash flow this year. Its Seagen and Metsera acquisitions target ...

Jim Cramer, the host of Mad Money, said on Thursday that the market is moving through a familiar rotation in which stocks ...

Cable One, Inc. (the "Company") today announced it has entered into a definitive agreement to acquire all of the equity interests in Mega Broadband Investments Holdings LLC ("MBI") that it does not ...

On paper, Ireland is richer than Singapore—and both are richer than the United States, Switzerland, and every country in the ...

American Healthcare REIT, Inc. (the "Company") announced today that it will issue its fourth quarter 2025 earnings release on Thursday, February 26, 2026, after the close of ...

From who owns the San Francisco 49ers to when they play next. Here's what to know about the five time Super Bowl championship ...

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...

Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched ...